Report Categories
View AllRecent Articles
View All
SOLS Q1 2026 Earnings EPS Misses Estimates Amid Operational Challenges
Ernexa Therapeutics Inc ERNA Q3 2023 Earnings Negative EPS as Company Advances Pipeline
AKBA Q1 2026 Earnings Slight EPS Miss Amid Continued Operational Progress
ACGLN Q1 2026 Earnings Preferred Share EPS Falls Slightly Short of Estimates Stock Edges Higher
CRISPR Therapeutics Q1 2026 Earnings Slight EPS Miss as Clinical Pipeline Progresses